Forschung und Entwicklung (F&E
Forschung und Entwicklung bei West Bengal Chemical Industries Limited (F&E)
Our team at West Bengal Chemical Industries Limited, is composed of industry-leading experts supported by cutting-edge resources. West Bengal Chemical Industries houses state-of-the-art equipment, technology, and instrumentation, empowering our research staff to excel in overall development of API. Leveraging advanced tools, we masterfully navigate product development, manufacturing, quality assurance, and technical support.
Our Research and Development (R&D) team is the innovation engine of our company. By blending scientific expertise with market demands, we conceive and develop new products. Our rigorous research and development process ensure we stay ahead of industry trends and deliver cutting-edge solutions to our customers.
| Apr. 01, 2025 | Liposomal Calcium: A Novel Nutraceutical Delivery Approach by West Bengal Chemical Industries Ltd., Kolkata, India | Open the Pdf Visit the Link |
| März 29, 2025 | Enhancing the stability and bioavailability of alpha-lipoic acid: Development and evaluation of a liposomal formulation | Open the Pdf Visit the Link |
| März 01, 2025 | Ferric Maltol of WBCIL: Optimized Absorption, Minimal Toxicity, And Sustainable Production for Chronic Iron Deficiency | Open the Pdf Visit the Link |
| Feb. 10, 2025 | Liposomal Glutathione: A breakthrough in cellular health by West Bengal chemical industries Ltd. | Open the Pdf Visit the Link |
| Feb. 10, 2025 | Stability, characterization, and manufacturing optimization of ferrous Ascorbate | Open the Pdf Visit the Link |
| Nov. 28, 2024 | Addressing Iron deficiency anemia in Bangladesh | Open the Pdf Visit the Link |
| Sep. 04, 2024 | Coral Calcium: A Superior Marine-Derived Calcium Supplement manufactured by WBCIL for Bone Health and beyond | Open the Pdf Visit the Link |
| Juli 26, 2024 | Liposomal Iron: A novel approach for improved iron supplementation, manufactured by WBCIL | Open the Pdf Visit the Link |
| Juli 11, 2024 | Quest Journals: Specialized Manufacturing of Calcium Lactate Gluconate (CLG) | Open the Pdf Visit the Link |
| Nov. 25, 2023 | IJFMR: Safety and Efficacy of FCM in the Management of Iron Deficiency Anaemia | Open the Pdf Visit the Link |
| Okt. 10, 2023 | IJSR: Evaluation of Hypersensitivity Reactions to Ferric Carboxymaltose in Iron | Open the Pdf Visit the Link |
| Products Name | CAS No. | Therapeutic Area | R&D Status |
|---|---|---|---|
| Kalzium Orotat | 22454-86-0 | Kalziumzusatz, B13-Cal | In Entwicklung |
| Kalzium D Saccharat USP | 5793-89-5 | Bluthochdruck, Osteoporose, Dickdarmkrebs | Unter Scale Up |
| Magnesium Pidolat EP | 135701-98-3 | Hämoglobin Sichelzellkrankheit bei Kindern, Hypomagnesiämie (Prophylaxe) Oral | In Entwicklung |
| Kalzium Pidolat | 31377-05-6 | Osteoporose | Entwickelt |
| Kalzium Levulinat Dihydrat USP | 34717-03-8 | Lebensmittelanreicherung | Entwickelt |
| Magnesium Aspartate Dihydrate BP | 215533-00-9 | Mineralstoffzusatz | Unter Scale Up |
| Methylcobalamine | 13422-55-4 | Mangel an Vitamin B12, Produktion von roten Blutkörperchen | In Entwicklung |
| Leucovorin Calcium (Reinheit 80% durch HPLC) | 1492-18-8 | Kolorektaler Krebs | In Entwicklung |
| L-Ornithin-L-Aspartat | 3230-94-2 | Hepatische Enzephalopathie auch als Antihistaminika verwendet. | In Entwicklung |
| Magnesiumlactat Gluconat | - | Gering schmeckende Magnesiumquelle in Lebensmitteln, Getränken und Nahrungsergänzungsmitteln | Entwickelt |
| Magnesium Orotat | 34717-03-8 | Mineralergänzungsmittel zur Behandlung von Magnesiummangel | Entwickelt |
| Kalzium Orotat | |
|---|---|
| CAS No. | 22454-86-0 |
| Therapeutic Area | Kalziumzusatz, B13-Cal |
| R&D Status | In Entwicklung |
| Kalzium D Saccharat USP | |
|---|---|
| CAS No. | 5793-89-5 |
| Therapeutic Area | Bluthochdruck, Osteoporose, Dickdarmkrebs |
| R&D Status | Unter Scale Up |
| Magnesium Pidolat EP | |
|---|---|
| CAS No. | 135701-98-3 |
| Therapeutic Area | Hämoglobin Sichelzellkrankheit bei Kindern, Hypomagnesiämie (Prophylaxe) Oral |
| R&D Status | In Entwicklung |
| Kalzium Pidolat | |
|---|---|
| CAS No. | 31377-05-6 |
| Therapeutic Area | Osteoporose |
| R&D Status | Entwickelt |
| Kalzium Levulinat Dihydrat USP | |
|---|---|
| CAS No. | 34717-03-8 |
| Therapeutic Area | Lebensmittelanreicherung |
| R&D Status | Entwickelt |
| Magnesium Aspartate Dihydrate BP | |
|---|---|
| CAS No. | 215533-00-9 |
| Therapeutic Area | Mineralstoffzusatz |
| R&D Status | Unter Scale Up |
| Methylcobalamine | |
|---|---|
| CAS No. | 13422-55-4 |
| Therapeutic Area | Mangel an Vitamin B12, Produktion von roten Blutkörperchen |
| R&D Status | In Entwicklung |
| Leucovorin Calcium (Reinheit 80% durch HPLC) | |
|---|---|
| CAS No. | 1492-18-8 |
| Therapeutic Area | Kolorektaler Krebs |
| R&D Status | In Entwicklung |
| L-Ornithin-L-Aspartat | |
|---|---|
| CAS No. | 3230-94-2 |
| Therapeutic Area | Hepatische Enzephalopathie auch als Antihistaminika verwendet. |
| R&D Status | In Entwicklung |
| Magnesiumlactat Gluconat | |
|---|---|
| CAS No. | - |
| Therapeutic Area | Gering schmeckende Magnesiumquelle in Lebensmitteln, Getränken und Nahrungsergänzungsmitteln |
| R&D Status | Entwickelt |
| Magnesium Orotat | |
|---|---|
| CAS No. | 34717-03-8 |
| Therapeutic Area | Mineralergänzungsmittel zur Behandlung von Magnesiummangel |
| R&D Status | Entwickelt |